mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
0.24 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |